Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $0.82.

  • Utah Medical Products' EPS (Weighted Average and Diluted) fell 1960.78% to $0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.54, marking a year-over-year decrease of 1709.6%. This contributed to the annual value of $3.96 for FY2024, which is 1334.79% down from last year.
  • As of Q3 2025, Utah Medical Products' EPS (Weighted Average and Diluted) stood at $0.82, which was down 1960.78% from $0.94 recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' EPS (Weighted Average and Diluted) ranged from a high of $1.25 in Q4 2022 and a low of $0.82 during Q3 2025
  • Over the past 5 years, Utah Medical Products' median EPS (Weighted Average and Diluted) value was $1.08 (recorded in 2023), while the average stood at $1.04.
  • Per our database at Business Quant, Utah Medical Products' EPS (Weighted Average and Diluted) skyrocketed by 16111.11% in 2021 and then tumbled by 2711.86% in 2024.
  • Over the past 5 years, Utah Medical Products' EPS (Weighted Average and Diluted) (Quarter) stood at $1.13 in 2021, then increased by 10.62% to $1.25 in 2022, then fell by 5.6% to $1.18 in 2023, then decreased by 27.12% to $0.86 in 2024, then fell by 4.65% to $0.82 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.82 for Q3 2025, versus $0.94 for Q2 2025 and $0.92 for Q1 2025.